T-cell repopulation and thymic volume in HIV-1-infected adult patients after highly active antiretroviral therapy

被引:111
|
作者
Franco, JM
Rubio, A
Martínez-Moya, M
Leal, M
Merchante, E
Sánchez-Quijano, A
Lissen, E
机构
[1] Hosp U Virgen Rocio, Dept Med Interna, Viral Hepatitis & AIDS Study Grp, Seville 41013, Spain
[2] Hosp U Virgen Rocio, Dept Radiol, Seville 41013, Spain
关键词
D O I
10.1182/blood.V99.10.3702
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The origin of T cells after highly active antiretroviral therapy (HAART) in patients infected with human immunodeficiency virus 1 (HIV-1) is now under discussion. The possibility of renewed lymphopoiesis in aged thymuses is still controversial. In this work we combine the analysis of naive T cells, T-cell receptor excision circles (TRECs), and computed tomography scanning of thymic tissue to further assess whether the thymus is involved in immune reconstitution. Fifteen antiretroviral-naive HIV-1-infected patients were evaluated during 48 weeks of HAART. At baseline, significant correlation was present among age and both thymic volume and TRECs, and between naive T cells and TRECs. After starting HAART, there was a significant increase at week 12 in naive CD4(+) and CD8(+) T cells, TRECs, and thymic volume. The initial net Increases in naive T cells and TREC counts were significantly correlated. Changes In thymic volume and TRECs were also indirectly related; splitting the population Into 2 groups of high and low baseline levels, only the group with low TREC levels had significant increases In both TRECs and thymic volume. Thus, the Increase in thymic volume might be functional, In response to depleted TREC levels. Taken together, our data strongly suggest a thymic role In Immune reconstitution, at least in patients with depleted baseline TREC levels. (C) 2002 by The American Society of Hematology.
引用
收藏
页码:3702 / 3706
页数:5
相关论文
共 50 条
  • [1] Baseline thymic volume is a predictor for CD4 T cell repopulation in adult HIV-infected patients under highly active antiretroviral therapy
    de la Rosa, R
    Leal, M
    Rubio, A
    Martinez-Moya, M
    Delgado, J
    Ruíz-Mateos, E
    Merchante, E
    Sánchez-Quijano, A
    Lissen, E
    [J]. ANTIVIRAL THERAPY, 2002, 7 (03) : 159 - 163
  • [2] T-cell apoptosis in HIV-1-infected individuals receiving highly active antiretroviral therapy
    Böhler, T
    Debatin, KM
    Wintergerst, U
    [J]. BLOOD, 2001, 97 (06) : 1898 - 1900
  • [3] Diversity of the T-cell receptor BV repertoire in HIV-1-infected patients reflects the biphasic CD4+ T-cell repopulation kinetics during highly active antiretroviral therapy
    Kostense, S
    Raaphorst, FM
    Notermans, DW
    Joling, J
    Hooibrink, B
    Pakker, NG
    Danner, SA
    Teale, JM
    Miedema, F
    [J]. AIDS, 1998, 12 (18) : F235 - F240
  • [4] Enhanced T-cell maturation, differentiation and function in HIV-1-infected individuals after growth hormone and highly active antiretroviral therapy
    Pires, A
    Pido-Lopez, J
    Moyle, G
    Gazzard, B
    Gotch, F
    Imami, N
    [J]. ANTIVIRAL THERAPY, 2004, 9 (01) : 67 - 75
  • [5] Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients
    Foudraine, NA
    Hovenkamp, E
    Notermans, DW
    Meenhorst, PL
    Klein, MR
    Lange, JMA
    Miedema, F
    Reiss, P
    [J]. AIDS, 1999, 13 (02) : 177 - 184
  • [6] Bacterial Meningitis in HIV-1-infected Patients in the Era of Highly Active Antiretroviral Therapy
    Domingo, Pere
    Suarez-Lozano, Ignacio
    Torres, Ferran
    Pomar, Virginia
    Ribera, Esteban
    Jose Galindo, Ma
    Cosin, Jaime
    Luisa Garcia-Alcalde, Ma
    Vidal, Francesc
    Lopez-Aldeguer, Jose
    Roca, Bernardino
    Gonzalez, Juan
    Lozano, Fernando
    Garrido, Myriam
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 51 (05) : 582 - 587
  • [7] T cell proliferation and apoptosis in HIV-1-infected lymphoid tissue: Impact of highly active antiretroviral therapy
    Dyrhol-Riise, AM
    Ohlsson, M
    Skarstein, K
    Nygaard, SJT
    Olofsson, J
    Jonsson, R
    Åsjö, B
    [J]. CLINICAL IMMUNOLOGY, 2001, 101 (02) : 180 - 191
  • [8] Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy
    DeSimone, JA
    Pomerantz, RJ
    Babinchak, TJ
    [J]. ANNALS OF INTERNAL MEDICINE, 2000, 133 (06) : 447 - 454
  • [9] Etravirine-based highly active antiretroviral therapy in HIV-1-infected paediatric patients
    Briz, V.
    Palladino, C.
    Navarro, M. L.
    Jimenez de Ory, S.
    Gonzalez-Tome, M. I.
    Leon, J. A.
    Nunez-Cuadros, E.
    de Jose, M. I.
    Ramos, J. T.
    Munoz-Fernandez, M. A.
    [J]. HIV MEDICINE, 2011, 12 (07) : 442 - 446
  • [10] Hyperglycosylated ferritin in sera of HIV-1-infected patients treated with highly active antiretroviral therapy
    Malvoisin, E
    Livrozet, JM
    Ducluzeau, PH
    Makloufi, D
    Cohen, R
    Vincent, N
    [J]. AIDS, 2006, 20 (03) : 457 - 459